Concerns about the reliability of a trial of oral progesterone for preterm birth included in a meta-analysis

Am J Obstet Gynecol MFM. 2022 Sep;4(5):100664. doi: 10.1016/j.ajogmf.2022.100664. Epub 2022 May 30.

Authors

Benjamin Y Gravesteijn¹, Jim G Thornton², Emmanouil Katsanevakis³, Ben Willem Mol⁴

Affiliations

¹ Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: b.gravesteijn@erasmusmc.nl.
² Department of Obstetrics and Gynaecology, University of Nottingham, Nottingham, United Kingdom.
³ Department of Obstetrics and Gynaecology, United Lincolnshire Hospitals Trust, Lincoln, United Kingdom.
⁴ Department of Obstetrcis and Gynaecology, Monash University, Clayton, Australia.

PMID: 35654321
DOI: 10.1016/j.ajogmf.2022.100664

No abstract available

Publication types

Letter
Meta-Analysis
Comment

MeSH terms

Cervical Length Measurement
Female
Humans
Infant, Newborn
Pregnancy
Premature Birth* / epidemiology
Premature Birth* / etiology
Premature Birth* / prevention & control
Progesterone*
Progestins / adverse effects
Reproducibility of Results

Substances

Progestins
Progesterone